Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24138Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Miltiadous, G. | en |
| dc.contributor.author | Mikhailidis, D. P. | en |
| dc.contributor.author | Elisaf, M. S. | en |
| dc.date.accessioned | 2015-11-24T19:38:20Z | - |
| dc.date.available | 2015-11-24T19:38:20Z | - |
| dc.identifier.issn | 1074-2484 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24138 | - |
| dc.rights | Default Licence | - |
| dc.subject | Acid-Base Imbalance/*chemically induced/*metabolism | en |
| dc.subject | Cardiovascular Agents/*adverse effects | en |
| dc.subject | Electrolytes/*metabolism | en |
| dc.subject | Humans | en |
| dc.subject | Treatment Failure | en |
| dc.subject | Water-Electrolyte Imbalance/*chemically induced/*metabolism | en |
| dc.title | Acid-base and electrolyte abnormalities observed in patients receiving cardiovascular drugs | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/14740076 | - |
| heal.identifier.secondary | http://cpt.sagepub.com/content/8/4/267.full.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2003 | - |
| heal.abstract | Cardiovascular drugs can cause a variety of acid-base and electrolyte abnormalities that need to be considered when clinicians manage the large number of patients who receive these agents. Diuretic-induced metabolic alkalosis is the most common acid-base disorder observed and is associated with hypokalemia. Drug-induced hyperkalemia is the most important cause of increased potassium levels in everyday clinical practice. Multifactorial-origin diuretic-induced hyponatremia is mostly due to thiazides and should be carefully managed. This review focuses on the pathogenetic mechanisms as well as on the treatment of these metabolic derangements that are commonly encountered in patients who receive cardiovascular drugs. | en |
| heal.journalName | J Cardiovasc Pharmacol Ther | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Miltiadous-2003-Acid-base and electr.pdf | 2.02 MB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
